Search Results 361-370 of 16175 for nivolumab

  1. Pemigatinib to Treat Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations - Mayo Clinic

    Nivolumab;; Anti-VEGF (vascular endothelial growth factor) monoclonal antibody, if eligible for this therapy;. Anti-EGFR (epidermal growth factor receptor) ...

  2. Clinical trials - Oncology (Medical)

    The purpose of this study is to evaluate the safety of pressurized intraperitoneal aerosol chemotherapy (PIPAC) in 2 groups of patients with peritoneal ...

  3. Probiotics Preventing Immune Checkpoint Inhibitor-Induced Colitis - Mayo Clinic

    For cohort 1: Ipilimumab with or without anti-PD-1/PD-L1 including but not limited to pembrolizumab, nivolumab, cemiplimab, atezolizumab, avelumab, or ...

  4. Clinical trials - Oncology (Medical)

    Scottsdale/Phoenix, Ariz. This phase II trial tests whether an exercise intervention works to improve cognitive function in breast cancer survivors. Many breast ...

  5. Peripheral nerve tumors - Doctors and departments - Mayo Clinic

    Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

  6. Enemy of My Enemy - Mayo Clinic News Network

    ... nivolumab. The researchers showed that this combination of virotherapy and immunotherapy significantly increased the survival of mice with malignant brain ...

  7. Patient Care - Center for Individualized Medicine - Mayo Clinic Research

    The center has established service lines in cancer, rare and undiagnosed diseases, pharmacogenomics, and predictive genomics and is integrating these services ...

  8. Peripheral nerve tumors - Doctors and departments - Mayo Clinic

    Learn about these growths that form in or near nerves connecting to the spinal cord. Surgery is the most common treatment.

  9. MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment - Mayo Clinic

    MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure ...

  10. Clinical trials - Oncology (Medical)

    The purpose of this study is to evaluate invasive disease-free survival (iDFS) of multi-epitope HER2 vaccine vs. placebo in combination with ado-trastuzumab ...